Janna Pape
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Janna Pape has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Michael von Wolff
Division of Gynecological Endocrinology and Reproductive Medicine, Women’s University Hospital, Inselspital Bern, University of Bern, 3010 Bern, Switzerland
16 shared publications - Angela Vidal
Department of Gynecology and Obstetrics, Women’s University Hospital, Inselspital Bern, 3010 Bern, Switzerland
10 shared publications - Tanya Karrer
Medical Library, University Library of Bern, University of Bern, 3012 Bern, Switzerland
9 shared publications - Susanna Weidlinger
Division of Gynecological Endocrinology and Reproductive Medicine, University Women’s Hospital, Inselspital Bern, University of Bern, 3010 Bern, Switzerland
6 shared publications Michael von Wolff
Division of Gynecological Endocrinology and Reproductive Medicine, University Womeńs Hospital, Inselspital Bern, University of Bern, Switzerland
5 shared publicationsJérémy Levy
FIVNAT statistician, Swiss Society for Reproductive Medicine, 5001 Aarau, Switzerland
4 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (11) , 2561
Dual Trigger in Poor Ovarian Responders: Do Improvements in Oocyte Maturation Translate into Better Reproductive Outcomes? A Systematic Review and Meta-Analysis
Background: Poor ovarian response (POR) represents a major challenge in assisted reproductive technology, frequently resulting in reduced oocyte yield and impaired reproductive outcomes. Dual trigger protocols combining gonadotropin-releasing hormone agonist (GnRH-a) with human chorionic gonadotropin (hCG) have been proposed to improve final oocyte maturation and pregnancy outcomes in women with POR classified according to the Bologna and POSEIDON criteria. However, available evidence remains inconsistent. Objective: To evaluate the effectiveness of dual trigger protocol compared with hCG trigger alone in women with poor ovarian response undergoing assisted reproductive treatment. Methods: A systematic review and meta-analysis was conducted according to PRISMA guidelines and registered in PROSPERO. MEDLINE, Embase, Cochrane CENTRAL, and Scopus were searched from 2000 to January 2026. Randomized and observational studies comparing dual triggers with hCG triggers alone in women diagnosed with poor ovarian response according to the Bologna and/or POSEIDON criteria were eligible. Outcomes included retrieved and mature (MII) oocytes, clinical pregnancy, miscarriage, and live birth. Random effects models were used for the primary analyses. Exploratory univariable meta-regression evaluated age, AFC, AMH, study design, and POR classification as potential moderators. Certainty of evidence was assessed using GRADE. Results: Twenty studies were included, of which 16 contributed data to at least one quantitative synthesis. Dual trigger was associated with a significantly higher number of mature (MII) oocytes in Bologna-defined women (MD 0.62, 95% CI 0.29–0.96; I2 = 83%) and in the overall population combining Bologna- and POSEIDON-defined women (MD 0.50, 95% CI 0.20–0.79; I2 = 91%), whereas no significant difference was observed in POSEIDON-defined women (MD 0.37, 95% CI −0.14 to 0.89; I2 = 93%). In the nested POSEIDON groups 3/4 subgroup, random effects analyses showed no significant differences in MII oocyte yield (MD 0.11, 95% CI −0.59 to 0.81), clinical pregnancy (OR 1.15, 95% CI 0.45–2.97), or live birth (OR 1.18, 95% CI 0.53–2.64). Lower miscarriage odds were observed in this subgroup (OR 0.43, 95% CI 0.30–0.63), based on two studies and heavily influenced by one large study. The number of retrieved oocytes was significantly higher with dual trigger protocol in Bologna-defined women (MD 0.71, 95% CI 0.33–1.09; I2 = 86%) and in the overall population (MD 0.62, 95% CI 0.27–0.97; I2 = 93%), but not in POSEIDON-defined women (MD 0.53, 95% CI −0.00 to 1.06; I2 = 91%); a separate estimate for POSEIDON groups 3/4 was unavailable. Clinical pregnancy was higher with dual trigger in Bologna-defined women (OR 1.29, 95% CI 1.03–1.61; I2 = 14%), whereas no significant difference was observed in POSEIDON-defined women (OR 1.10, 95% CI 0.78–1.56; I2 = 68%). No significant differences were observed for miscarriage or live birth in the overall analyses. Sensitivity analyses excluding studies at high or serious overall risk of bias attenuated the associations for oocyte-related outcomes in the combined population, although they persisted in Bologna-defined women, and did not demonstrate significant differences in reproductive outcomes. Exploratory meta-regression identified no significant effect modification by age, AFC, AMH, study design, or POR classification (all p > 0.05). Conclusions: Dual trigger may modestly improve oocyte yield and maturation in women with poor ovarian response, although these effects appear to vary according to POR classification and were attenuated in sensitivity analyses excluding studies at high or serious risk of bias. Although higher clinical pregnancy rates were observed in Bologna-defined women, no significant benefit was demonstrated for miscarriage or live birth. Thus, the available evidence suggests a potential effect of dual trigger on intermediate ovarian outcomes but does not establish that these improvements translate into better reproductive outcomes. Further adequately powered randomized controlled trials are needed to determine whether specific subgroups of poor ovarian responders may derive a clinically meaningful benefit.
- 6 November 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (11) , 2561
Open AccessDual Trigger in Poor Ovarian Responders: Do Improvements in Oocyte Maturation Translate into Better Reproductive Outcomes? A Systematic Review and Meta-Analysis
Background: Poor ovarian response (POR) represents a major challenge in assisted reproductive technology, frequently resulting in reduced oocyte yield and impaired reproductive outcomes. Dual trigger protocols combining gonadotropin-releasing hormone agonist (GnRH-a) with human chorionic gonadotropin (hCG) have been proposed to improve final oocyte maturation and pregnancy outcomes in women with POR classified according to the Bologna and POSEIDON criteria. However, available evidence remains inconsistent. Objective: To evaluate the effectiveness of dual trigger protocol compared with hCG trigger alone in women with poor ovarian response undergoing assisted reproductive treatment. Methods: A systematic review and meta-analysis was conducted according to PRISMA guidelines and registered in PROSPERO. MEDLINE, Embase, Cochrane CENTRAL, and Scopus were searched from 2000 to January 2026. Randomized and observational studies comparing dual triggers with hCG triggers alone in women diagnosed with poor ovarian response according to the Bologna and/or POSEIDON criteria were eligible. Outcomes included retrieved and mature (MII) oocytes, clinical pregnancy, miscarriage, and live birth. Random effects models were used for the primary analyses. Exploratory univariable meta-regression evaluated age, AFC, AMH, study design, and POR classification as potential moderators. Certainty of evidence was assessed using GRADE. Results: Twenty studies were included, of which 16 contributed data to at least one quantitative synthesis. Dual trigger was associated with a significantly higher number of mature (MII) oocytes in Bologna-defined women (MD 0.62, 95% CI 0.29–0.96; I2 = 83%) and in the overall population combining Bologna- and POSEIDON-defined women (MD 0.50, 95% CI 0.20–0.79; I2 = 91%), whereas no significant difference was observed in POSEIDON-defined women (MD 0.37, 95% CI −0.14 to 0.89; I2 = 93%). In the nested POSEIDON groups 3/4 subgroup, random effects analyses showed no significant differences in MII oocyte yield (MD 0.11, 95% CI −0.59 to 0.81), clinical pregnancy (OR 1.15, 95% CI 0.45–2.97), or live birth (OR 1.18, 95% CI 0.53–2.64). Lower miscarriage odds were observed in this subgroup (OR 0.43, 95% CI 0.30–0.63), based on two studies and heavily influenced by one large study. The number of retrieved oocytes was significantly higher with dual trigger protocol in Bologna-defined women (MD 0.71, 95% CI 0.33–1.09; I2 = 86%) and in the overall population (MD 0.62, 95% CI 0.27–0.97; I2 = 93%), but not in POSEIDON-defined women (MD 0.53, 95% CI −0.00 to 1.06; I2 = 91%); a separate estimate for POSEIDON groups 3/4 was unavailable. Clinical pregnancy was higher with dual trigger in Bologna-defined women (OR 1.29, 95% CI 1.03–1.61; I2 = 14%), whereas no significant difference was observed in POSEIDON-defined women (OR 1.10, 95% CI 0.78–1.56; I2 = 68%). No significant differences were observed for miscarriage or live birth in the overall analyses. Sensitivity analyses excluding studies at high or serious overall risk of bias attenuated the associations for oocyte-related outcomes in the combined population, although they persisted in Bologna-defined women, and did not demonstrate significant differences in reproductive outcomes. Exploratory meta-regression identified no significant effect modification by age, AFC, AMH, study design, or POR classification (all p > 0.05). Conclusions: Dual trigger may modestly improve oocyte yield and maturation in women with poor ovarian response, although these effects appear to vary according to POR classification and were attenuated in sensitivity analyses excluding studies at high or serious risk of bias. Although higher clinical pregnancy rates were observed in Bologna-defined women, no significant benefit was demonstrated for miscarriage or live birth. Thus, the available evidence suggests a potential effect of dual trigger on intermediate ovarian outcomes but does not establish that these improvements translate into better reproductive outcomes. Further adequately powered randomized controlled trials are needed to determine whether specific subgroups of poor ovarian responders may derive a clinically meaningful benefit.
- Open Access
- 6 September 2026
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 327, 115418
Predicting success in IVF: How the first cycle shapes the next
- 6 September 2026
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 327, 115418
Open AccessPredicting success in IVF: How the first cycle shapes the next
- 2 August 2026
- Published by Springer Nature
- p. 483-491
Fertility Treatment Using Cryopreserved Gametes and Tissue
- 2 August 2026
- Published by Springer Nature
- p. 483-491
Fertility Treatment Using Cryopreserved Gametes and Tissue
- 2 August 2026
- Published by Springer Nature
- p. 347-359
Transplantation of Ovarian Tissue
- 2 August 2026
- Published by Springer Nature
- p. 213-224
Testicular Cancer
- 2 August 2026
- Published by Springer Nature
- p. 87-100
Acute Leukemia
- Open Access
Fertility Outcomes in Leukemia Survivors by Treatment Modality: A Systematic Review and Meta-Analysis
Introduction: Leukemia is the most common childhood malignancy. Treatment requires urgent polychemotherapy and may escalate to hematopoietic stem cell transplantation (HSCT) with or without total body irradiation (TBI). Due to the frequently young age at diagnosis, time limitations and unpredictable course, fertility preservation (FP) is especially challenging and may not be feasible prior to treatment, particularly in females. Methods: We conducted a systematic review and meta-analysis of fertility outcomes in leukemia survivors using MEDLINE, Embase, and Cochrane databases (search date: 13 June 2024). Results: Forty-two studies with 2048 patients were included. Overall infertility was 37% (95% CI 23–54%) with substantial heterogeneity. The highest infertility rates were observed after HSCT (68%) and after testicular irradiation (92%) or TBI ≥ 10–12 Gy (66%). Chemotherapy alone was associated with lower infertility (4%). Sex-specific differences were noted, with higher infertility in males following chemotherapy-only regimens (18% vs. 6% in females), while females were more affected after HSCT (70% vs. 59% in males). Subfertility affected about one-fifth of survivors. Conclusions: While standard chemotherapy is associated with relatively low gonadotoxicity, HSCT and irradiation confer substantial risk. These findings support individualized fertility counseling and long-term reproductive follow-up based on treatment exposure.
Open AccessFertility Outcomes in Leukemia Survivors by Treatment Modality: A Systematic Review and Meta-Analysis
Introduction: Leukemia is the most common childhood malignancy. Treatment requires urgent polychemotherapy and may escalate to hematopoietic stem cell transplantation (HSCT) with or without total body irradiation (TBI). Due to the frequently young age at diagnosis, time limitations and unpredictable course, fertility preservation (FP) is especially challenging and may not be feasible prior to treatment, particularly in females. Methods: We conducted a systematic review and meta-analysis of fertility outcomes in leukemia survivors using MEDLINE, Embase, and Cochrane databases (search date: 13 June 2024). Results: Forty-two studies with 2048 patients were included. Overall infertility was 37% (95% CI 23–54%) with substantial heterogeneity. The highest infertility rates were observed after HSCT (68%) and after testicular irradiation (92%) or TBI ≥ 10–12 Gy (66%). Chemotherapy alone was associated with lower infertility (4%). Sex-specific differences were noted, with higher infertility in males following chemotherapy-only regimens (18% vs. 6% in females), while females were more affected after HSCT (70% vs. 59% in males). Subfertility affected about one-fifth of survivors. Conclusions: While standard chemotherapy is associated with relatively low gonadotoxicity, HSCT and irradiation confer substantial risk. These findings support individualized fertility counseling and long-term reproductive follow-up based on treatment exposure.
- Open Access
- 10 April 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (4) , 871
The Role of Endometrial Microbiota in the Pathogenesis of Chronic Endometritis: A Systematic Review and Meta-Analysis
Background: Chronic endometritis (CE) is a subtle, often asymptomatic endometrial inflammation marked by CD138+ plasma cell infiltration and linked to recurrent implantation failure (RIF), recurrent pregnancy loss (RPL), and unexplained infertility. Emerging evidence implicates endometrial microbiome dysbiosis in CE. Objective: To systematically review and conduct meta-analysis on the association between CE and endometrial microbiome alterations and their reproductive implications. Methods: We searched MEDLINE, Embase, Web of Science, Scopus, Cochrane CENTRAL, and Google Scholar for studies diagnosing CE via CD138 immunostaining, assessing microbiota with molecular techniques. Data extraction, quality assessment, and meta-analysis were performed. Results: Twenty-two studies including 4022 women were analyzed. CE was associated with reduced prevalence of Lactobacillus-dominated microbiota and increased detection of non-Lactobacillus species, particularly Streptococcus spp., Enterococcus spp., Escherichia coli, Staphylococcus spp., Ureaplasma spp., and Gardnerella vaginalis. In the meta-analysis (2947 women), Enterococcus spp. and Ureaplasma spp. were significantly more prevalent in women with CE, whereas Streptococcus spp., E. coli, Staphylococcus spp. and G. vaginalis showed non-significant trends. Only E. coli and Streptococcus spp. showed significant heterogeneity between-studies. Conclusions: CE is linked to microbial dysbiosis with reduced Lactobacillus dominance and enrichment of potentially pathogenic taxa, notably Enterococcus and Ureaplasma spp. These findings suggest that the endometrial microbiome contributes to chronic inflammation and adverse reproductive outcomes, yet heterogeneity and limited evidence call for standardized diagnostics and robust trials before clinical implementation.
- 10 April 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (4) , 871
Open AccessThe Role of Endometrial Microbiota in the Pathogenesis of Chronic Endometritis: A Systematic Review and Meta-Analysis
Background: Chronic endometritis (CE) is a subtle, often asymptomatic endometrial inflammation marked by CD138+ plasma cell infiltration and linked to recurrent implantation failure (RIF), recurrent pregnancy loss (RPL), and unexplained infertility. Emerging evidence implicates endometrial microbiome dysbiosis in CE. Objective: To systematically review and conduct meta-analysis on the association between CE and endometrial microbiome alterations and their reproductive implications. Methods: We searched MEDLINE, Embase, Web of Science, Scopus, Cochrane CENTRAL, and Google Scholar for studies diagnosing CE via CD138 immunostaining, assessing microbiota with molecular techniques. Data extraction, quality assessment, and meta-analysis were performed. Results: Twenty-two studies including 4022 women were analyzed. CE was associated with reduced prevalence of Lactobacillus-dominated microbiota and increased detection of non-Lactobacillus species, particularly Streptococcus spp., Enterococcus spp., Escherichia coli, Staphylococcus spp., Ureaplasma spp., and Gardnerella vaginalis. In the meta-analysis (2947 women), Enterococcus spp. and Ureaplasma spp. were significantly more prevalent in women with CE, whereas Streptococcus spp., E. coli, Staphylococcus spp. and G. vaginalis showed non-significant trends. Only E. coli and Streptococcus spp. showed significant heterogeneity between-studies. Conclusions: CE is linked to microbial dysbiosis with reduced Lactobacillus dominance and enrichment of potentially pathogenic taxa, notably Enterococcus and Ureaplasma spp. These findings suggest that the endometrial microbiome contributes to chronic inflammation and adverse reproductive outcomes, yet heterogeneity and limited evidence call for standardized diagnostics and robust trials before clinical implementation.
- Open Access
Hodgkin Lymphoma—The Effect of Chemotherapy on Gonadal Function and Fertility Is Strongly Related to the Treatment Regimen, Age, and Sex: A Systematic Review and Meta-Analysis
Background/Objectives: Hodgkin lymphoma (HL) primarily affects individuals of reproductive age, making gonadal dysfunction after chemotherapy a critical survivorship concern. While fertility preservation options including gamete and gonadal tissue cryopreservation are available before treatment, evidence-based counseling requires regimen-specific risk estimates accounting for patient age and sex. Therefore, a meta-analysis was performed to assess presumed infertility in HL patients, stratified by chemotherapy regimen, age, and sex. Methods: This systematic review and meta-analysis, conducted within the FertiTOX project, included studies published between 2000 and February 2024. Eligible studies reported gonadal function outcomes ≥ 1 year after chemotherapy, excluding patients who received pelvic radiotherapy or stem cell transplantation, or had recurrent disease. Presumed infertility was defined by surrogate markers, including amenorrhea, premature ovarian failure, or abnormal hormonal levels in women, and azoospermia, oligozoospermia, or abnormal hormonal levels in men. Results: Of 2376 screened studies, 50 were included (meta-analysis: 43 studies; 5564 female and 1631 male patients). Overall presumed infertility prevalence was 21% in women (95% CI: 0.14–0.29) and 45% in men (95% CI: 0.29–0.62). The highest prevalence occurred after BEACOPP (women 38%; men 81%), while ABVD was associated with the lowest (6% each in women and men). Childhood/adolescent HL treatment resulted in lower prevalence in women (8%) but remained high in men (67%). Conclusions: Fertility risk depends on regimen, age, and sex, requiring tailored counseling. For female children/adolescents and all patients receiving ABVD, post-treatment fertility evaluation and treatment may suffice. However, pre-treatment fertility preservation is strongly recommended for male adolescents and patients receiving other regimens.
Open AccessHodgkin Lymphoma—The Effect of Chemotherapy on Gonadal Function and Fertility Is Strongly Related to the Treatment Regimen, Age, and Sex: A Systematic Review and Meta-Analysis
Background/Objectives: Hodgkin lymphoma (HL) primarily affects individuals of reproductive age, making gonadal dysfunction after chemotherapy a critical survivorship concern. While fertility preservation options including gamete and gonadal tissue cryopreservation are available before treatment, evidence-based counseling requires regimen-specific risk estimates accounting for patient age and sex. Therefore, a meta-analysis was performed to assess presumed infertility in HL patients, stratified by chemotherapy regimen, age, and sex. Methods: This systematic review and meta-analysis, conducted within the FertiTOX project, included studies published between 2000 and February 2024. Eligible studies reported gonadal function outcomes ≥ 1 year after chemotherapy, excluding patients who received pelvic radiotherapy or stem cell transplantation, or had recurrent disease. Presumed infertility was defined by surrogate markers, including amenorrhea, premature ovarian failure, or abnormal hormonal levels in women, and azoospermia, oligozoospermia, or abnormal hormonal levels in men. Results: Of 2376 screened studies, 50 were included (meta-analysis: 43 studies; 5564 female and 1631 male patients). Overall presumed infertility prevalence was 21% in women (95% CI: 0.14–0.29) and 45% in men (95% CI: 0.29–0.62). The highest prevalence occurred after BEACOPP (women 38%; men 81%), while ABVD was associated with the lowest (6% each in women and men). Childhood/adolescent HL treatment resulted in lower prevalence in women (8%) but remained high in men (67%). Conclusions: Fertility risk depends on regimen, age, and sex, requiring tailored counseling. For female children/adolescents and all patients receiving ABVD, post-treatment fertility evaluation and treatment may suffice. However, pre-treatment fertility preservation is strongly recommended for male adolescents and patients receiving other regimens.
- Open Access
- 6 November 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (11) , 2728
Uterine Contractility Changes in Adenomyosis: Evidence from a Systematic Review and Meta-Analysis
Background: The presence of ectopic endometrial glands within the uterine myometrium in patients with adenomyosis has been associated with adverse fertility outcomes. UP (Uterine Peristalsis), a movement of contractions at the junctional zone of the non-pregnant uterus, can be impacted by an altered architecture of uterine layers. Abnormal contractility patterns could impact both uterotubal sperm transport as well as embryo implantation. Because of this potential influence on clinical symptoms and reproduction in patients with adenomyosis, studies have been analyzing the feasibility of diagnostic techniques in assessing uterine peristalsis. Objective: This systematic review and meta-analysis aimed to detect an alteration in patterns of UP in patients with adenomyosis. Methods: A systematic literature search of Medline, Embase, Cochrane, CENTRAL databases and Google Scholar was conducted up to June 2025, including studies evaluating UP and adenomyosis. Clinical studies evaluating uterine contractility were included, excluding those potentially affected by therapeutic interventions. The meta-analysis pooled data from studies to compare uterine contractility direction between patients with adenomyosis and control groups. Results: In seven included studies (442 women), uterine contractility varied significantly in association with menstrual cycle phases and pathological conditions. The meta-analysis revealed two statistically significant findings: women with adenomyosis showed significantly reduced uterine contraction frequency (SMD −1.81, 95% CI: −3.04 to −0.58, p = 0.0039) and fewer antegrade contractions (OR 0.35, 95% CI: 0.13–0.96, p = 0.0423) compared to controls. Other contractility patterns showed non-significant trends with substantial heterogeneity. Conclusions: Our findings show a significant difference in uterine contraction patterns in patients with adenomyosis compared to controls, namely a decrease in frequency and an increased number of retrograde uterine contractions in the adenomyosis group. The remarkable heterogeneity of the results highlighted the need for larger study cohorts in the future, especially to address the main diagnostic possibilities and treatments in order to improve reproductive outcomes.
- 6 November 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (11) , 2728
Open AccessUterine Contractility Changes in Adenomyosis: Evidence from a Systematic Review and Meta-Analysis
Background: The presence of ectopic endometrial glands within the uterine myometrium in patients with adenomyosis has been associated with adverse fertility outcomes. UP (Uterine Peristalsis), a movement of contractions at the junctional zone of the non-pregnant uterus, can be impacted by an altered architecture of uterine layers. Abnormal contractility patterns could impact both uterotubal sperm transport as well as embryo implantation. Because of this potential influence on clinical symptoms and reproduction in patients with adenomyosis, studies have been analyzing the feasibility of diagnostic techniques in assessing uterine peristalsis. Objective: This systematic review and meta-analysis aimed to detect an alteration in patterns of UP in patients with adenomyosis. Methods: A systematic literature search of Medline, Embase, Cochrane, CENTRAL databases and Google Scholar was conducted up to June 2025, including studies evaluating UP and adenomyosis. Clinical studies evaluating uterine contractility were included, excluding those potentially affected by therapeutic interventions. The meta-analysis pooled data from studies to compare uterine contractility direction between patients with adenomyosis and control groups. Results: In seven included studies (442 women), uterine contractility varied significantly in association with menstrual cycle phases and pathological conditions. The meta-analysis revealed two statistically significant findings: women with adenomyosis showed significantly reduced uterine contraction frequency (SMD −1.81, 95% CI: −3.04 to −0.58, p = 0.0039) and fewer antegrade contractions (OR 0.35, 95% CI: 0.13–0.96, p = 0.0423) compared to controls. Other contractility patterns showed non-significant trends with substantial heterogeneity. Conclusions: Our findings show a significant difference in uterine contraction patterns in patients with adenomyosis compared to controls, namely a decrease in frequency and an increased number of retrograde uterine contractions in the adenomyosis group. The remarkable heterogeneity of the results highlighted the need for larger study cohorts in the future, especially to address the main diagnostic possibilities and treatments in order to improve reproductive outcomes.